Econometric approaches in evaluating costs and outcomes within pharmacoeconomic analyses

Pharmaceuticals Policy and Law

Volumn 14, Issue 1, 2012, Pages 105-122

  Skrepnek, Grant H ^a   Olvey, Eleanor L ^a   Sahai, Ashok ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

costs and outcomes; Regression; retrospective databases

Indexed keywords

ARTICLE; CALCULATION; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DECISION MAKING; HEALTH CARE COST; HEALTH CARE POLICY; LINEAR REGRESSION ANALYSIS; MAXIMUM LIKELIHOOD METHOD; METHODOLOGY; OUTCOME ASSESSMENT; PHARMACOECONOMICS; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 84856915907     PISSN: 13892827     EISSN: 2210495X     Source Type: Journal    
DOI: 10.3233/PPL-2011-0345     Document Type: Article

References (41)

1. G.H. Skrepnek, Balancing Cost, Quality, and Access to Care Among Payers, Providers, and Patients: The Sword of Damocles, Arizona Med 19(2) (2008), 18-27.
2. A.R. Willan and A.H. Briggs, Statistical Analysis of Cost-effectiveness Data, Hoboken, New Jersey: Wiley, 2006.
3. S.D. Sullivan, J. Watkins, B. Sweet and S.D. Ramsey, Health Technology Assessment in Health-Care Decisions in the United States, Value Health 12(S2) (2009), S39-S44.
4. J.C. O'Donnell, S.V. Pham, C.L. Pashos and D.W. Miller, Health Technology Assessment: Lessons Learned from Around the World - An Overview, Value Health 12(S2) (2009), S1-S5.
5. G.H. Skrepnek, Regression Methods in the Empiric Analysis of Health Care Data, J Managed Care Pharm 11 (2005), 240-251.
6. M.D.H. Motulsky, Intuitive Biostatistics, New York: Oxford University Press, 1995.
7. A.H. Studenmund, Using Econometrics: A Practical Guide, 4th edition. New York: Addison Wesley, 2001.
8. S.A. Glantz and B.K. Slinker, Primer of Applied Regression and Analysis of Variance, 2nd edition. New York: McGraw-Hill, 1990.
9. D.N. Gujarati, Basic Econometrics, 3rd edition. New York: McGraw Hill, 1995.
10. R.E. Santerre and S.P. Neun, Health Economics: Theory, Insights, and Industry Studies, 5th edition. Mason, Ohio: South-Western Cengage, 2010.
11. G.H. Skrepnek, Cost-Effectiveness Analysis, in: Principles of PharmacoEconomics, J.L. Bootman, R.J. Townsend and W.F. McGhan, eds, 3rd Edition. Cincinnati: W Harvey Whitney Books Company, 2005, pp. 83-116.
12. J. Neter, M.H. Kutner, C.J. Nachtsheim and W. Wasserman, Applied Linear Statistical Models, 4th edition. Chicago: Irwin, 1996.
13. N. Duan, Smearing Estimate: A Nonparametric Retransformation Method, J Am Stat Assoc 78(383) (1983), 605-610.
14. J.W. Hardin and J.M. Hilbe, Generalized Linear Models and Extensions, 2nd edition. College Station, Texas: Stata Press, 2007.
15. R.J. Thornton and J.T. Innes, Interpreting Semi-Logarithmic Regression in Labor Research, J Labor Res 10(4) (1989), 443-447.
16. A. Agresti, Relation odds and relative risk, in: An Introduction to Categorical Data Analysis, New York: Wiley, 1996.
17. P. Diehr, D. Yanez, A. Ash, M. Hornbrook and D.Y. Lin, Methods for Analyzing Costs and Utilization, Annual Rev Pub Health 20 (1999), 125-144.
18. W.G. Manning, The logged dependent variable, heteroscedasticity, and the retransformation problem, J Health Econ 17 (1998), 283-295. (Pubitemid 28300217)
19. W.G. Manning and J. Mullahy, Estimating log models: To transform or not to transform, J Health Econ 20 (2001), 461-494. (Pubitemid 32515166)
20. J. Mullahy, Much ado about two: reconsidering retransformation and the two-part model in health econometrics, J Health Econ 17 (1998), 247-281. (Pubitemid 28300216)
21. D. Madden, Sample selection versus two-part models revisited: The case of female smoking and drinking, J Health Econ 27(2) (2008), 300-307.
22. E.B. Andersen, Asymptotic Properties of Conditional Maximum Likelihood Estimators, J Royal Stat Soc Series B (Methodological) 32(2) (1970), 283-301.
23. T.W. Anderson, Asymptotically efficient estimation of covariance matrices with linear structure, Annals Sci 1(1) (1973), 135-141.
24. R.B. Millar, Maximum Likelihood Estimation and Inference, Hoboken, New Jersey: Wiley, 2011.
25. P. McCullagh and J.A. Nelder, Generalized Linear Models, 2nd Edition. New York: Chapman & Hall, 2000.
26. D.K. Blough and S.D. Ramsey, Using Generalized Linear Models to Assess Medical Care Costs, Health Serv Outcomes Res Method 1(2) (2000), 185-202. (Pubitemid 32798848)
27. J.M. Hilbe, Negative Binomial Regression, 2nd edition. Cambridge, Massachusetts: Cambridge University Press, 2011.
28. J. Abarca and E.P. Armstrong, Multiple logistic regression: a statistical method to evaluate predictors of hospitalizations, Formulary 35 (2000), 832-841.
29. D.W. Hosmer and S. Lemeshow, Applied Logistic Regression, 2nd edition. John Wiley & Sons: New York, 2000.
30. D.W. Hosmer, S. Lemeshow and S. May, Applied Survival Analysis: Regression Modeling of Time to Event Data, John Wiley & Sons: New York, 2008.
31. D.Y. Lin, E.J. Feuer, R. Etzioni and Y. Wax, Estimating medical costs from incomplete follow-up data, Biometrics 53 (1997), 419-434. (Pubitemid 27262208)
32. H. Bang and A.A. Tsiatis, Estimating medical costs with censored data, Biometrika 87 (2000), 329-343.
33. M. Arellano, Panel Data Econometrics, New York: Oxford University Press, 2003.
34. B.H. Baltagi, Econometric Analysis of Panel Data, 3rd edition. Hoboken, New Jersey: Wiley, 2005.
35. J.M. Wooldridge, Econometric Analysis of Cross Section and Panel Data, Cambridge. Massachusetts: MIT Press, 2002.
36. A.M. Jones, N. Rice, T. Bago d'Uva and S. Balia, Applied Health Economics, New York: Routledge, 2007.
37. J.A. Hausman, Specification Tests in Econometrics, Econometrica 46(6) (1978), 1251-1271.
38. J.W. Hardin and J.M. Hilbe, Generalized Estimating Equations, Washington, DC: Chapman and Hall, 2003.
39. C.E. McCulloch, S.R. Searle and J.M. Neuhaus, Generalized, Linear, and Mixed Models, 2nd edition. Hoboken, New Jersey: Wiley, 2008.
40. G.H. Skrepnek, The Frequentist Approach to Statistical Inference, in: Encyclopedia of Medical Decision Making, M.W. Kattan, ed., Thousand Oaks, California: Sage, 2009.
41. G.H. Skrepnek, The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis, Pharmacoeconomics 25(8) (2007), 649-664. (Pubitemid 47124167)